340 related articles for article (PubMed ID: 32476261)
21. The Global Impact of COVID-19 on Solid Organ Transplantation: Two Years Into a Pandemic.
Nimmo A; Gardiner D; Ushiro-Lumb I; Ravanan R; Forsythe JLR
Transplantation; 2022 Jul; 106(7):1312-1329. PubMed ID: 35404911
[TBL] [Abstract][Full Text] [Related]
22. SARS-CoV-2 infection and early mortality of waitlisted and solid organ transplant recipients in England: A national cohort study.
Ravanan R; Callaghan CJ; Mumford L; Ushiro-Lumb I; Thorburn D; Casey J; Friend P; Parameshwar J; Currie I; Burnapp L; Baker R; Dudley J; Oniscu GC; Berman M; Asher J; Harvey D; Manara A; Manas D; Gardiner D; Forsythe JLR
Am J Transplant; 2020 Nov; 20(11):3008-3018. PubMed ID: 32780493
[TBL] [Abstract][Full Text] [Related]
23. COVID-19 and kidney transplantation: Results from the TANGO International Transplant Consortium.
Cravedi P; Mothi SS; Azzi Y; Haverly M; Farouk SS; Pérez-Sáez MJ; Redondo-Pachón MD; Murphy B; Florman S; Cyrino LG; Grafals M; Venkataraman S; Cheng XS; Wang AX; Zaza G; Ranghino A; Furian L; Manrique J; Maggiore U; Gandolfini I; Agrawal N; Patel H; Akalin E; Riella LV
Am J Transplant; 2020 Nov; 20(11):3140-3148. PubMed ID: 32649791
[TBL] [Abstract][Full Text] [Related]
24. Donor and transplant candidate selection for solid organ transplantation during the COVID-19 pandemic.
Galvan NTN; Moreno NF; Garza JE; Bourgeois S; Hemmersbach-Miller M; Murthy B; Timmins K; O'Mahony CA; Anton J; Civitello A; Garcha P; Loor G; Liao K; Shaffi A; Vierling J; Stribling R; Rana A; Goss JA
Am J Transplant; 2020 Nov; 20(11):3113-3122. PubMed ID: 32524743
[TBL] [Abstract][Full Text] [Related]
25. Promising effects of tocilizumab in COVID-19: A non-controlled, prospective clinical trial.
Dastan F; Saffaei A; Haseli S; Marjani M; Moniri A; Abtahian Z; Abedini A; Kiani A; Seifi S; Jammati H; Hashemian SMR; Pourabdollah Toutkaboni M; Eslaminejad A; Heshmatnia J; Sadeghi M; Nadji SA; Dastan A; Baghaei P; Varahram M; Yousefian S; Salamzadeh J; Tabarsi P
Int Immunopharmacol; 2020 Nov; 88():106869. PubMed ID: 32889241
[TBL] [Abstract][Full Text] [Related]
26. Recovery of COVID-19 acute respiratory distress syndrome with tocilizumab: successful outcome in two critically ill patients.
Cala-García JD; Sierra-Bretón JD; Cavelier-Baiz JE; Faccini-Martínez ÁA; Pérez-Díaz CE
Immunotherapy; 2020 Oct; 12(15):1127-1132. PubMed ID: 32664810
[No Abstract] [Full Text] [Related]
27. Compassionate Use of Tocilizumab for Treatment of SARS-CoV-2 Pneumonia.
Jordan SC; Zakowski P; Tran HP; Smith EA; Gaultier C; Marks G; Zabner R; Lowenstein H; Oft J; Bluen B; Le C; Shane R; Ammerman N; Vo A; Chen P; Kumar S; Toyoda M; Ge S; Huang E
Clin Infect Dis; 2020 Dec; 71(12):3168-3173. PubMed ID: 32575124
[TBL] [Abstract][Full Text] [Related]
28. Reduction in the risk of progression of solid organ transplant recipients infected by SARS-CoV-2 treated with monoclonal antibodies.
Candel FJ; Salavert M; Lorite Mingot D; Manzano Crespo M; Pérez Portero P; Cuervo Pinto R
Rev Esp Quimioter; 2023 Aug; 36(4):380-391. PubMed ID: 37089055
[TBL] [Abstract][Full Text] [Related]
29. Interleukin-6 receptor antagonist therapy to treat SARS-CoV-2 driven inflammatory syndrome in a kidney transplant recipient.
Allam SR; Dao A; Madhrira MM; Antiporta PB; Nair RR; Guiteau JJ; Reyad AI
Transpl Infect Dis; 2020 Aug; 22(4):e13326. PubMed ID: 32406985
[No Abstract] [Full Text] [Related]
30. A prospective, randomised, double blind placebo-controlled trial to evaluate the efficacy and safety of tocilizumab in patients with severe COVID-19 pneumonia (TOC-COVID): A structured summary of a study protocol for a randomised controlled trial.
Rilinger J; Kern WV; Duerschmied D; Supady A; Bode C; Staudacher DL; Wengenmayer T
Trials; 2020 Jun; 21(1):470. PubMed ID: 32493514
[TBL] [Abstract][Full Text] [Related]
31. COVID-19: transplant works toward adaptation.
Pullen LC
Am J Transplant; 2020 Oct; 20(10):2633-2634. PubMed ID: 32996294
[TBL] [Abstract][Full Text] [Related]
32. Reinfection with SARS-CoV-2 in solid-organ transplant recipients: Incidence density and convalescent immunity prior to reinfection.
Morris S; Anjan S; Pallikkuth S; Frattaroli P; Courel S; Fernandez A; Natori A; Abbo L; Pahwa S; Guerra G; Natori Y
Transpl Infect Dis; 2022 Jun; 24(3):e13827. PubMed ID: 35338554
[TBL] [Abstract][Full Text] [Related]
33. Clinical outcomes in COVID-19 patients treated with tocilizumab: An individual patient data systematic review.
Antwi-Amoabeng D; Kanji Z; Ford B; Beutler BD; Riddle MS; Siddiqui F
J Med Virol; 2020 Nov; 92(11):2516-2522. PubMed ID: 32436994
[TBL] [Abstract][Full Text] [Related]
34. Monoclonal antibody treatment for COVID-19 in solid organ transplant recipients.
Sarrell BA; Bloch K; El Chediak A; Kumm K; Tracy K; Forbes RC; Langone A; Thomas L; Schlendorf K; Trindade AJ; Perri R; Wright P; Concepcion BP
Transpl Infect Dis; 2022 Feb; 24(1):e13759. PubMed ID: 34787345
[TBL] [Abstract][Full Text] [Related]
35. Tocilizumab as a Treatment for 'Cytokine Storm Syndrome' in COVID-19: A Case Report.
Syam AF; Pitoyo CW; Suhendro S; Zulkarnain B; Indrasari ND; Aditianingsih D; Irawan C; Susilo A; Rumende CM; Wijaya IP; Ibrahim F; Rasmin M; Alwi I; Makmun D
Acta Med Indones; 2021 Apr; 53(2):194-201. PubMed ID: 34251348
[TBL] [Abstract][Full Text] [Related]
36. Clinical characteristics and outcomes of COVID-19 in solid organ transplant recipients: A cohort study.
Chaudhry ZS; Williams JD; Vahia A; Fadel R; Parraga Acosta T; Prashar R; Shrivastava P; Khoury N; Pinto Corrales J; Williams C; Nagai S; Abouljoud M; Samaniego-Picota M; Abreu-Lanfranco O; Del Busto R; Ramesh MS; Patel A; Alangaden GJ
Am J Transplant; 2020 Nov; 20(11):3051-3060. PubMed ID: 32654332
[TBL] [Abstract][Full Text] [Related]
37. The Combined Use of Tocilizumab and Hemoadsorption in a Patient with SARS-COV-2-19-Associated Pneumonia: A Case Report.
Berlot G; Tomasini A; Roman Pognuz E; Randino A; Chiella F; La Fata C; Piva M; Amato P; di Maso V; Bianco F; Gerini U; Tomietto P; Trenti T
Nephron; 2020; 144(9):459-462. PubMed ID: 32694244
[TBL] [Abstract][Full Text] [Related]
38. SARS-CoV-2 infection increases tacrolimus concentrations in solid-organ transplant recipients.
Salerno DM; Kovac D; Corbo H; Jennings DL; Lee J; Choe J; Scheffert J; Hedvat J; Chen J; Tsapepas D; Rosenblatt R; Samstein B; Halazun K; Verna E; Pereira M; Brennan C; Husain SA; Mohan S; Brown RS
Clin Transplant; 2021 Mar; 35(3):e14193. PubMed ID: 33336440
[No Abstract] [Full Text] [Related]
39. Early Experience With COVID-19 and Solid Organ Transplantation at a US High-volume Transplant Center.
Yi SG; Rogers AW; Saharia A; Aoun M; Faour R; Abdelrahim M; Knight RJ; Grimes K; Bullock S; Hobeika M; McMillan R; Mobley C; Moaddab M; Huang HJ; Bhimaraj A; Ghobrial RM; Gaber AO
Transplantation; 2020 Nov; 104(11):2208-2214. PubMed ID: 32496357
[TBL] [Abstract][Full Text] [Related]
40. SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity.
Wei J; Zhao J; Han M; Meng F; Zhou J
J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32727811
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
